{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-251274","form_type":"8-K","ticker":"OACC","cik":"0002029769","company_name":"Oaktree Acquisition Corp. III Life Sciences","filed_at":"2024-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.601049+00:00","generated_at":"2026-05-30T05:33:15.864438+00:00","sec_items":["3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Oaktree Acquisition Corp. III Life Sciences closes partial over-allotment, trust grows to $192M","bullets":["Underwriters purchased 1,699,029 additional units at $10.00 each, generating $16.99M gross proceeds.","Sponsor purchased 33,981 additional private placement units at $10.00 each for $339,810.","Sponsor forfeited 231,492 Class B ordinary shares at no cost as part of the over-allotment exercise.","Remaining 925,971 over-allotment units were forfeited by underwriters.","Total trust account now holds $191,990,290 from IPO, over-allotment, and private placement proceeds."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-251274","json":"https://secwatch.observer/filing/0001193125-24-251274.json","markdown":"https://secwatch.observer/filing/0001193125-24-251274.md","text":"https://secwatch.observer/filing/0001193125-24-251274.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2029769/000119312524251274/0001193125-24-251274-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2029769/000119312524251274/d852268d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:33:15.864438+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}